954226-60-9 Usage
Uses
Used in Pharmaceutical Industry:
2-Cyclopropylpyrimidine-5-carbaldehyde serves as a key intermediate in the synthesis of pharmaceuticals, contributing to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
2-Cyclopropylpyrimidine-5-carbaldehyde is also utilized as an intermediate in the production of agrochemicals, playing a role in the creation of pesticides and other agricultural products to enhance crop protection and yield.
Used in Fine Chemicals Synthesis:
2-Cyclopropylpyrimidine-5-carbaldehyde is an important building block for the synthesis of fine chemicals, which are high-purity, specialty chemicals used in various industries, including fragrances, flavors, and cosmetics.
Used in Medicinal and Pharmacological Research:
Due to its reactivity and ability to engage in various organic reactions, 2-Cyclopropylpyrimidine-5-carbaldehyde holds promise in medicinal and pharmacological research. It can be used to create diverse molecular structures that may modulate biological processes and interact with specific molecular targets within living organisms, potentially leading to the discovery of new treatments and therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 954226-60-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,4,2,2 and 6 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 954226-60:
(8*9)+(7*5)+(6*4)+(5*2)+(4*2)+(3*6)+(2*6)+(1*0)=179
179 % 10 = 9
So 954226-60-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H8N2O/c11-5-6-3-9-8(10-4-6)7-1-2-7/h3-5,7H,1-2H2
954226-60-9Relevant articles and documents
HETEROARYL SUBSTITUTED HETEROCYCLYL SULFONES
-
Page/Page column 38; 39, (2015/11/09)
The invention relates to aryl substituted heterocyclyl sulfones as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
Cyclic Amines
-
Paragraph 0145, (2014/05/07)
The present invention is directed to novel cyclic amines which inhibit the P2X7 receptor.
